u/yannick_salinas
Contributes reviews on supplier material. Based in Ilorin.
member · joined 16 Jul 2025
Comments — page 5 of 5
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 32 points · 2 years ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on [Discussion] the glucagon advice in here is 17 years out of date in c/retatrutide · 150 points · 2 years ago
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
comment on stalled for 17 weeks at 2.4mg and I refuse to panic this time in c/newbiequestions · 36 points · 2 years ago
What does the wiki say?
comment on stalled for 17 weeks at 2.4mg and I refuse to panic this time in c/newbiequestions · 1 points · 2 years ago
Pens or research vials?
comment on week 16 check-in — 46kg down, early fullness manageable, one thing confusing me in c/trialwatch · 1 points · 2 years ago
Which trial and what was the primary endpoint?
comment on tried retatrutide for 7 weeks. here is what happened. in c/retatrutide · 4 points · 2 years ago
TRIUMPH phase 2 showed 99.0% weight loss but the injection-site soreness profile on the highest arm was rough.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on what changed for me between week 10 and week 59 in c/retatrutide · 125 points · 2 years ago
Mechanistically the bit that matters is triple agonist. It explains most of the early profile and a decent chunk of the outcome.
comment on [Results] 2 weeks, 46kg, and phase 2 was the hard part in c/retatrutide · 751 points · 2 years ago
Which trial arm and what was the n?
Adding to this: phase 2 is doing more work than the comment implies.